ArticleBMC pediatrics2026
Predictors of mortality in children with community-acquired pneumonia admitted to paediatric intensive care units in Sri Lanka: a retrospective, multi-center cohort study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo describe the demographic, clinical, and laboratory characteristics as predictors of mortality of children with severe community-acquired pneumonia (CAP) admitted to paediatric intensive care units in Sri Lanka.
methodsWe conducted a multi-center retrospective study among children with severe CAP admitted to all paediatric intensive care units (PICUs) from April 2018 to March 2020. The primary outcomes were mortality and length of PICU stay. Univariate and multivariate logistic regression analyses were used to identify the potential predictors of mortality.
resultsRecords of 266 children with community-acquired pneumonia were studied. Mortality rate was 30.8%. 72% had at least one comorbidity. Mortality was higher among children < 1 year compared to children ≥ 5 years (aOR:5.69, CI:1.297,24.931, p = 0.02). Also, septic shock (aOR:12.04, CI:5.287,27.416, p < 0.001), invasive ventilation (aOR:4.92, CI: 2.34, 10.387, p < 0.001), comorbidities (aOR:7.75, CI:2.563,23.437, p < 0.001), leucopenia/leukocytosis (< 4 or > 15 × 109) (aOR:2.16, CI:1.030,4.531, p = 0.04) and multilobar involvement (aOR:3.44, CI:1.128,10.470, p = 0.03) increased the risk of mortality. The effect size was highest in cases involving septic shock unresponsive to fluid boluses and the presence of one or more comorbid conditions, as identified through regression analysis.
conclusionsThe mortality rate among children with community-acquired pneumonia was high in this study population. Younger age, the need for invasive ventilation, septic shock, underlying comorbidities and multilobar involvement were identified as statistically significant independent predictors of mortality. However, the high mortality rate observed may also reflect other contributing factors not captured within the scope of this study, highlighting the need for further research to explore these influences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.